This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

LeadingBiotech: Cancer Advance
March 5, 2020
Koch Institute for Integrative Cancer Research at MITCambridge, MA

Amy Mahery
Senior Vice President, Head of Global Market Access and Pricing at EMD Serono


Amy Mahery is Senior Vice President and Head of Global Market Access & Pricing (GMAP). In this role, she leads global value, access, and pricing strategy and execution across all therapeutic franchises and markets from clinical development to late lifecycle. She has been with EMD Serono for 15 years.

Prior to this role, Amy was the Vice President of GMAP where she oversaw the development and implementation of access strategies and pricing guidance for all products in the Neurology and Immunology portfolio. Just before that, she was the GMAP Pipeline Lead for the oncology franchise where she helped to shape clinical trials for critical assets such as bintrafusp-alpha and tepotinib.

Before joining the global organization, Amy held multiple commercial roles on the US team. She was the Brand Lead for evofosfamide and led the launch of Bavencio in urothelial carcinoma. Amy also worked in U.S. Market Access as the Director Marketing and Contracting Strategy for Rebif. She spent five years on the neurology marketing team in various roles supporting cladribine tablets and Rebif, and the three years prior as a Neurology Sales Training Manager.

Amy has more than 20 years of experience in the biopharmaceutical industry. Before joining EMD Serono, she worked as a Corporate Specialty Trainer and Sales Representative at Johnson & Johnson. She holds a holds a B.S. in Neuroscience from Trinity College.

Agenda Sessions

  • Pricing of Oncology Drugs